Skip to main content

Advertisement

SpringerLink
Log in

Public biotech 2009—the numbers

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

An Erratum to this article was published on 13 October 2010

This article has been updated

The public biotech sector sustained more losses in 2009, but the year ended on a positive note, and the industry has regained its footing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Global biotech industry financing.
Figure 2: Global biotech initial public offerings.
Figure 3: Public biotech company revenue, R&D spending, profits and number of employees by market cap.

Change history

  • 13 October 2010

    In the version of this article initially published, in Table 6, Acorda was said to have entered into a licensing agreement with Bayer. In fact, Acorda entered into a licensing agreement with Biogen, not Bayer. The error has been corrected in the HTML and PDF versions of the article.

Acknowledgements

The authors would like to acknowledge the insight of G. Giovannetti and G. Jaggi in crafting this article.

Author information

Authors and Affiliations

  1. Data retrieval for this article was by Ernst & Young (Boston) with additional reporting by Riku Lähteenmäki.,

    Riku Lähteenmäki

  2. Brady Huggett is business editor at Nature Biotechnology.,

    Brady Huggett

  3. John Hodgson is editor-at-large at Nature Biotechnology.,

    John Hodgson

  4. Riku Lähteenmäki is a freelance writer in Turku, Finland.,

    Riku Lähteenmäki

Authors
  1. Brady Huggett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riku Lähteenmäki
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huggett, B., Hodgson, J. & Lähteenmäki, R. Public biotech 2009—the numbers. Nat Biotechnol 28, 793–799 (2010). https://doi.org/10.1038/nbt0810-793

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0810-793

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation